Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ringborg

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Anti-Cancer Drugs|October 1, 1990
Cell death in relation to cell cycle in a mouse ascites tumor growing in vivo after combined treatment with cisplatin and 5-fluorouracilF Lewin, S Skog, B Tribukait, et al.
Experimental Cell Research|October 1, 1979
Increase of uv-induced DNA repair synthesis during blast transformation of human lymphocytesR Lewensohn, D Killander, U Ringborg, et al.
In Vivo (Athens, Greece)|July 1, 1989
Effect of cis-diammino-dichloro-platinum (II) on cell growth and cell cycle progression of a mouse ascites tumor growing in vivoF Lewin, S Skog, B Tribukait, et al.
Experimental Cell Research|February 1, 1973
Quantitative micro-assay for RNA-DNA hybrids in the study of nucleolar RNA from Chironomus tentans salivary gland cellsB Lambert, E Egyházi, B Daneholt, et al.
Acta Medica Scandinavica|January 1, 1976
A case report including EM and DNA repair investigations in a dermatosis associated with multiple skin cancers: epidermodysplasia verruciformisH Hammar, L Hammar, L Lambert, et al.
Anticancer Research|January 1, 1991
Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell linesR Lewensohn, H Ehrsson, J Hansson, et al.
Cancer Treatment Reports|October 1, 1978
Sister chromatid exchanges in lymphocyte cultures of patients receiving chemotherapy for malignant disordersB Lambert, U Ringborg, E Harper, et al.
The Journal of Investigative Dermatology|November 6, 1998
N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skinS Jiveskog, B Ragnarsson-Olding, A Platz, et al.
American Journal of Epidemiology|December 1, 1990
Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984M Thörn, R Bergström, H O Adami, et al.
Melanoma Research|June 1, 1994
Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutationsA Platz, U Ringborg, E M Brahme, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Anti-Cancer Drugs|October 1, 1990
Cell death in relation to cell cycle in a mouse ascites tumor growing in vivo after combined treatment with cisplatin and 5-fluorouracilF Lewin, S Skog, B Tribukait, et al.
Experimental Cell Research|October 1, 1979
Increase of uv-induced DNA repair synthesis during blast transformation of human lymphocytesR Lewensohn, D Killander, U Ringborg, et al.
In Vivo (Athens, Greece)|July 1, 1989
Effect of cis-diammino-dichloro-platinum (II) on cell growth and cell cycle progression of a mouse ascites tumor growing in vivoF Lewin, S Skog, B Tribukait, et al.
Experimental Cell Research|February 1, 1973
Quantitative micro-assay for RNA-DNA hybrids in the study of nucleolar RNA from Chironomus tentans salivary gland cellsB Lambert, E Egyházi, B Daneholt, et al.
Acta Medica Scandinavica|January 1, 1976
A case report including EM and DNA repair investigations in a dermatosis associated with multiple skin cancers: epidermodysplasia verruciformisH Hammar, L Hammar, L Lambert, et al.
Anticancer Research|January 1, 1991
Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell linesR Lewensohn, H Ehrsson, J Hansson, et al.
Cancer Treatment Reports|October 1, 1978
Sister chromatid exchanges in lymphocyte cultures of patients receiving chemotherapy for malignant disordersB Lambert, U Ringborg, E Harper, et al.
The Journal of Investigative Dermatology|November 6, 1998
N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skinS Jiveskog, B Ragnarsson-Olding, A Platz, et al.
American Journal of Epidemiology|December 1, 1990
Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984M Thörn, R Bergström, H O Adami, et al.
Melanoma Research|June 1, 1994
Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutationsA Platz, U Ringborg, E M Brahme, et al.
Pageof 16